by The Mount Sinai Hospital Credit: Unsplash/CC0 Public Domain A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The therapy, known...
